24 Oct CLSI has provided testing and interpretive criteria for common organisms. • Labs occasionally need to test “infrequently isolated or fastidious”. 15 Aug Home; CLSI M45 Clinical and Laboratory Standards Institute document M Methods for Antimicrobial Dilution and Disk CLSI MA2. D(ABMM) Thomas R. CLSI document MA2 (ISBN ).clsi. contact us at: Telephone: West Valley Road. in vitro antimicrobial.
|Published (Last):||10 October 2007|
|PDF File Size:||19.95 Mb|
|ePub File Size:||18.17 Mb|
|Price:||Free* [*Free Regsitration Required]|
— Page Not Found
Jorgensen, PhD, chairholder of the CLSI working group that developed the clsi m45-a2, it has long been accepted that for the most effective management of bacterial infections, laboratories must be able to clsi m45-a2 susceptibility or resistance to therapeutic agents. Prompt, accurate identification of a bacterial pathogen is clsi m45-a2 of the most valuable services the microbiology laboratory provides for clinicians in its efforts clsi m45-a2 positively impact patient care.
In such cases, in vitro antimicrobial susceptibility of the organism isolated is most likely indicated. Oxford University Press is a department of the University of Oxford. This guideline is based somewhat on standardized procedures in other documents, but contains specific instructions on when and how to perform antimicrobial susceptibility testing of fastidious or infrequently isolated organisms that might be resistant to cls commonly prescribed through antibiotics. His e-mail address is glenmcdan aol.
Full Clsi m45-a2 If a bacterial pathogen’s susceptibility to antimicrobial agents cannot be predicted based on the identity of the organism alone, in vitro antimicrobial susceptibility testing of the isolated organism may be indicated. The performance, applications, and limitations of the current CLSI-recommended methods are described.
M45 does not suggest that laboratories test all infrequently m5-a2 or fastidious isolates, especially if they are clsi m45-a2 dubious clinical significance, Dr.
Its encompassing nature establishes M45 as an invaluable resource to various constituencies, including the clinical laboratory. The clsi m45-a2 described are generic reference methods that can clsi m45-a2 used for routine susceptibility testing by most clinical laboratories. Close mobile search navigation Article navigation. According to Clsi m45-a2 H. Commercial clsi m45-a2 testing devices are not specifically addressed by M While comprehensive, the guideline is not prescriptive, and allows some degree of customization of criteria and policies by each laboratory and its medical staff.
Jorgensen offers an example of how this clsi m45-a2 might be used in a typical laboratory. Jorgensen theorizes that diagnostic device companies may even modify their products to gain regulatory eg, FDA clearance for marketing to clinical laboratories. CLSI is a global, nonprofit organization that promotes the development and use of voluntary consensus standards and guidelines within the health care community.
clsi m45-a2 However, clinicians need prompt guidance on treating m45-s2 that can cause serious, life-threatening infections eg, bacteremia, endocarditis, and meningitis. View all product details. Susceptibility testing is especially necessary if the etiological agent is resistant, or possibly resistant, to clsi m45-a2 commonly used antimicrobial agent. Results generated by these reference methods may in fact be used by regulatory agencies to evaluate the performance of commercial cosi as part of clsi m45-a2 approval systems.
Jorgenson stresses the importance of understanding their distinction from M Working group member Paul C.
The Experts James H. However, there are instances in clsi m45-a2 the sensitivity of such a pathogen cannot be predicted simply based on the identity of the organism.
A clsi m45-a2 of laboratory techniques can be used to measure the in vitro susceptibility of bacteria to antimicrobial agents. Jorgensen and Hindler both agree that this revised guideline is very timely, in light of the increasingly common challenges faced by clsi m45-a2 performing susceptibility testing on these organisms, including increased pressure from clinicians to provide susceptibility data quickly, and the need for reliable methods to identify emerging resistance.
Susceptibility testing is particularly necessary in those situations in which the etiological agent belongs clssi clsi m45-a2 bacterial species for which resistance to commonly used antimicrobial agents has been documented, or could arise.
Jorgensen identifies these developments as the most obvious benefits of M Email alerts New issue alert. Not Logged In Member?: